Johnson & Johnson earnings: Time to talk about drug prices By: MarketWatch July 16, 2018 at 14:18 PM EDT The drug pricing controversy isn’t going away anytime soon, hardly good news for pharmaceutical companies. Read More >> Related Stocks: Allergan Plc Bristol-Myers Squibb Johnson & Johnson Merck & Co Pfizer